{
  "request": {
    "url": "https://query2.finance.yahoo.com/v10/finance/quoteSummary/ABBV?formatted=false&modules=assetProfile&crumb=haT3oykhHqZ",
    "method": "GET",
    "headers": {
      "cookie": "GUCS=AV78X-IQ; GUC=AQABCAFnsytn2UIgTASn&s=AQAAAEKG89vA&g=Z7HctQ; A3=d=AQABBKvcsWcCEIGLkyl67hr2YX7XekV46j4FEgABCAErs2fZZ_bPb2UB9qMAAAcIq9yxZ63aZoI&S=AQAAAtFJa---IoVh8DRgGhGzVr4; A1S=d=AQABBKvcsWcCEIGLkyl67hr2YX7XekV46j4FEgABCAErs2fZZ_bPb2UB9qMAAAcIq9yxZ63aZoI&S=AQAAAtFJa---IoVh8DRgGhGzVr4; EuConsent=CQM66kAQM66kAAOACBENBcFoAP_gAEPgACiQKptB9G7WTXFneXp2YPskOYUX0VBJ4MAwBgCBAcABzBIUIBwGVmAzJEyIICACGAIAIGBBIABtGAhAQEAAYIAFAABIAEgAIBAAIGAAACAAAABACAAAAAAAAAAQgEAXMBQgmAYEBFoIQUhAggAgAQAAAAAEAIgBCgQAEAAAQAAICAAIACgAAgAAAAAAAAAEAFAIEQAAIAECAotkdQAAAAAAAAAAAAQACAABAAAAAIKpgAkGpUQBFgSEhAIGEECAEQUBABQIAgAACBAAAATBAUIAwAVGAiAEAIAAAAAAAAACABAAABAAhAAEAAQIAAAAAIAAgAIBAAACAAAAAAAAAAAAAAAAAAAAAAAAAGIBAggAAABBAAQUAAAAAgAAAAAAAAAIgACAAAAAAAAAAAAAAIgAAAAAAAAAAAAAAAAAAIAAAAIAAAAgBEFgAAAAAAAAAAAAAACAABAAAAAIAAA; A1=d=AQABBKvcsWcCEIGLkyl67hr2YX7XekV46j4FEgABCAErs2fZZ_bPb2UB9qMAAAcIq9yxZ63aZoI&S=AQAAAtFJa---IoVh8DRgGhGzVr4",
      "user-agent": "@gadicc/yahoo-finance2/0.0.1 (+https://github.com/gadicc/node-yahoo-finance2)"
    }
  },
  "response": {
    "ok": true,
    "status": 200,
    "statusText": "OK",
    "headers": {
      "age": "0",
      "cache-control": "public, max-age=1, stale-while-revalidate=9",
      "content-type": "application/json;charset=utf-8",
      "date": "Mon, 24 Feb 2025 09:34:43 GMT",
      "referrer-policy": "no-referrer-when-downgrade",
      "server": "ATS",
      "strict-transport-security": "max-age=31536000",
      "vary": "Origin,Accept-Encoding",
      "x-content-type-options": "nosniff",
      "x-envoy-decorator-operation": "finance-company-fundamentals-api--mtls-production-ir2.finance-k8s:4080/*",
      "x-envoy-upstream-service-time": "2",
      "x-frame-options": "SAMEORIGIN",
      "x-xss-protection": "1; mode=block",
      "y-rid": "1b5ars5jrof9j"
    },
    "bodyJson": {
      "quoteSummary": {
        "result": [
          {
            "assetProfile": {
              "address1": "1 North Waukegan Road",
              "city": "North Chicago",
              "state": "IL",
              "zip": "60064-6400",
              "country": "United States",
              "phone": "847 932 7900",
              "website": "https://www.abbvie.com",
              "industry": "Drug Manufacturers - General",
              "industryKey": "drug-manufacturers-general",
              "industryDisp": "Drug Manufacturers - General",
              "sector": "Healthcare",
              "sectorKey": "healthcare",
              "sectorDisp": "Healthcare",
              "longBusinessSummary": "AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Beh√ßet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",
              "fullTimeEmployees": 55000,
              "companyOfficers": [
                {
                  "maxAge": 1,
                  "name": "Mr. Richard A. Gonzalez",
                  "age": 70,
                  "title": "Executive Chairman",
                  "yearBorn": 1954,
                  "fiscalYear": 2023,
                  "totalPay": {
                    "raw": 7190594,
                    "fmt": "7.19M",
                    "longFmt": "7,190,594"
                  },
                  "exercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  },
                  "unexercisedValue": {
                    "raw": 47864680,
                    "fmt": "47.86M",
                    "longFmt": "47,864,680"
                  }
                },
                {
                  "maxAge": 1,
                  "name": "Mr. Scott T. Reents",
                  "age": 56,
                  "title": "Executive VP & CFO",
                  "yearBorn": 1968,
                  "fiscalYear": 2023,
                  "totalPay": {
                    "raw": 3132761,
                    "fmt": "3.13M",
                    "longFmt": "3,132,761"
                  },
                  "exercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  },
                  "unexercisedValue": {
                    "raw": 5589906,
                    "fmt": "5.59M",
                    "longFmt": "5,589,906"
                  }
                },
                {
                  "maxAge": 1,
                  "name": "Dr. Azita  Saleki-Gerhardt Ph.D.",
                  "age": 61,
                  "title": "Executive VP & COO",
                  "yearBorn": 1963,
                  "fiscalYear": 2023,
                  "totalPay": {
                    "raw": 3510428,
                    "fmt": "3.51M",
                    "longFmt": "3,510,428"
                  },
                  "exercisedValue": {
                    "raw": 5248500,
                    "fmt": "5.25M",
                    "longFmt": "5,248,500"
                  },
                  "unexercisedValue": {
                    "raw": 23376292,
                    "fmt": "23.38M",
                    "longFmt": "23,376,292"
                  }
                },
                {
                  "maxAge": 1,
                  "name": "Mr. Jeffrey Ryan Stewart",
                  "age": 54,
                  "title": "Executive VP & Chief Commercial Officer",
                  "yearBorn": 1970,
                  "fiscalYear": 2023,
                  "totalPay": {
                    "raw": 4315363,
                    "fmt": "4.32M",
                    "longFmt": "4,315,363"
                  },
                  "exercisedValue": {
                    "raw": 2125307,
                    "fmt": "2.13M",
                    "longFmt": "2,125,307"
                  },
                  "unexercisedValue": {
                    "raw": 9617938,
                    "fmt": "9.62M",
                    "longFmt": "9,617,938"
                  }
                },
                {
                  "maxAge": 1,
                  "name": "Dr. Roopal  Thakkar M.D.",
                  "age": 51,
                  "title": "Executive VP of Research and Development & Chief Scientific Officer",
                  "yearBorn": 1973,
                  "fiscalYear": 2023,
                  "exercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  },
                  "unexercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  }
                },
                {
                  "maxAge": 1,
                  "name": "Ms. Elizabeth  Shea",
                  "title": "Senior Vice President of Investor Relations",
                  "fiscalYear": 2023,
                  "exercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  },
                  "unexercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  }
                },
                {
                  "maxAge": 1,
                  "name": "Mr. Perry C. Siatis",
                  "age": 48,
                  "title": "Executive VP, General Counsel & Secretary",
                  "yearBorn": 1976,
                  "fiscalYear": 2023,
                  "exercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  },
                  "unexercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  }
                },
                {
                  "maxAge": 1,
                  "name": "Mr. Sanjay  Narayan",
                  "title": "Senior VP, Chief Ethics, Compliance Officer & Allergan Aesthetic Legal",
                  "fiscalYear": 2023,
                  "exercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  },
                  "unexercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  }
                },
                {
                  "maxAge": 1,
                  "name": "Mr. Timothy J. Richmond",
                  "age": 58,
                  "title": "Executive VP & Chief Human Resources Officer",
                  "yearBorn": 1966,
                  "fiscalYear": 2023,
                  "totalPay": {
                    "raw": 1121841,
                    "fmt": "1.12M",
                    "longFmt": "1,121,841"
                  },
                  "exercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  },
                  "unexercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  }
                },
                {
                  "maxAge": 1,
                  "name": "Mr. Wulff-Erik  von Borcke",
                  "title": "Senior VP & President of Oncology",
                  "fiscalYear": 2023,
                  "exercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  },
                  "unexercisedValue": {
                    "raw": 0,
                    "fmt": null,
                    "longFmt": "0"
                  }
                }
              ],
              "auditRisk": 4,
              "boardRisk": 4,
              "compensationRisk": 3,
              "shareHolderRightsRisk": 9,
              "overallRisk": 7,
              "governanceEpochDate": 1738368000,
              "compensationAsOfEpochDate": 1703980800,
              "executiveTeam": [],
              "maxAge": 86400
            }
          }
        ],
        "error": null
      }
    }
  }
}